PCN21 DRUG UTILIZATION, COST CONSIDERATIONS AND TRANSFUSION PATTERNS FOR ERYTHROPOIETIC STIMULATING AGENTS IN A MANAGED CARE CANCER POPULATION
May 1, 2007, 00:00 AM
10.1016/S1098-3015(10)68932-2
https://www.valueinhealthjournal.com/article/S1098-3015(10)68932-2/fulltext
Section Title :
Section Order :
111
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68932-2&doi=10.1016/S1098-3015(10)68932-2